I’ll take just 1 dose please! Hehehe! Now talk about a expensive drug!!
$Orchard Therapeutics(ORTX.US$ Orchard Therapeutics (ORTX), recently acquired by Kyowa Kirin (OTCPK:KYKOY), has set its newly FDA-approved rare disease therapy Lenmeldy at a wholesale price of $4.25M on Wednesday, making one-time gene therapy the world's costliest medicine.
Early this week, the FDA approved Lenmeldy as the first U.S. treatment for early-onset metachromatic leukodystrophy (MLD), a rare metabolic disorder.
The British company noted that the drug's wholesale acquisition cost (WAC) which indicates the drug's list price, reflects the value its medicine delivers to patients, their families, and the overall healthcare system.
WAC excludes elements such as rebates and discounts and may not be a patient's final cost, which also depends on health insurance.
The company added that its pricing was in line with a recent review by the drug pricing watchdog, the Institute for Clinical and Economic Review (ICER). The non-profit indicated up to a $3.94M health benefit
Early this week, the FDA approved Lenmeldy as the first U.S. treatment for early-onset metachromatic leukodystrophy (MLD), a rare metabolic disorder.
The British company noted that the drug's wholesale acquisition cost (WAC) which indicates the drug's list price, reflects the value its medicine delivers to patients, their families, and the overall healthcare system.
WAC excludes elements such as rebates and discounts and may not be a patient's final cost, which also depends on health insurance.
The company added that its pricing was in line with a recent review by the drug pricing watchdog, the Institute for Clinical and Economic Review (ICER). The non-profit indicated up to a $3.94M health benefit
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
STD0313 : How can you call yourself a non profit organization with a statement like this........loosely written.....our new therapy provides (3 or 4 forgot) million in benefits to the patient so 14 million .........only 10 million over what we have determined is the actual value to the customer......oh and that is a discount rate
STD0313 : What is wrong with this world
TrytosaveabitOP STD0313: Hehehe! They gotta pay the research bills and pay the staff!
TrytosaveabitOP STD0313: A lot my friend, a lot